![]()
|
|
||||||||
J. Biol. Chem., Vol. 277, Issue 2, 1405-1418, January 11, 2002
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the Departments of RelB mediates the constitutive nuclear pool of
NF-
RelB Cellular Regulation and Transcriptional Activity Are
Regulated by p100*
,
,
,
, and
§¶
Immunology and
§ Experimental Pathology and Laboratory Medicine and the
¶ Division of Infectious Diseases, Mayo Clinic,
Rochester, Minnesota 55905
B transcriptional activity in myeloid and lymphoid cells, which
is believed to be secondary to its weak interaction with the classical
NF-
B inhibitor proteins, the I
Bs. In other cell types, RelB is
located in the cytosol, thus suggesting that RelB is also regulated by an inhibitory protein(s). In this study, it is demonstrated that RelB
is associated in the cytosol with p100 but not with I
B
, I
B
,
I
B
, nor p105. Its cytosolic control is not affected by stimuli
that lead to RelA nuclear translocation, and RelB nuclear localization
is prevented by p100, but not by p105 or I
B
. Structure function
analysis p100-RelB interactions indicates that p100 amino acids
623-900 are required for effective interaction and repression of
nuclear translocation and RelB driven NF-
B-dependent
transcription. Moreover, this carboxyl-portion of p100 contains
a nuclear export signal(s), which is required for effective retrieval
of RelB from the nucleus. Finally, overexpression of NF-
B-inducing
kinase, a kinase that has recently been shown to induce p100
processing, possibly through IKK
activation, causes nuclear
translocation of RelB protein. Thus, these studies indicate that p100
is a bone fide inhibitor of RelB and that this transcription factor may be regulated by NF-
B-inducing kinase and/or IKK
.
*
This work was supported by National Institutes of Health
Grant R01 AI36076 and the Mayo Foundation.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
To whom correspondence should be addressed: Mayo Clinic, 200 First St. SW, Guggenheim 501, Rochester, MN 55905. Tel.: 507-284-3747; Fax: 507-284-3757; E-mail: paya@mayo.edu.
This article has been cited by other articles:
![]() |
A. J. Fusco, O. V. Savinova, R. Talwar, J. D. Kearns, A. Hoffmann, and G. Ghosh Stabilization of RelB Requires Multidomain Interactions with p100/p52 J. Biol. Chem., May 2, 2008; 283(18): 12324 - 12332. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Wang, B. Zhang, L. Yang, J. Ding, and H.-F. Ding Constitutive Production of NF-{kappa}B2 p52 Is Not Tumorigenic but Predisposes Mice to Inflammatory Autoimmune Disease by Repressing Bim Expression J. Biol. Chem., April 18, 2008; 283(16): 10698 - 10706. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. K. Srivastava, X. Qin, N. Wedhas, M. Arnush, T. A. Linkhart, R. B. Chadwick, and A. Kumar Tumor Necrosis Factor-{alpha} Augments Matrix Metalloproteinase-9 Production in Skeletal Muscle Cells through the Activation of Transforming Growth Factor- -activated Kinase 1 (TAK1)-dependent Signaling Pathway J. Biol. Chem., November 30, 2007; 282(48): 35113 - 35124. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Souvannavong, N. Saidji, and R. Chaby Lipopolysaccharide from Salmonella enterica Activates NF-{kappa}B through both Classical and Alternative Pathways in Primary B Lymphocytes Infect. Immun., October 1, 2007; 75(10): 4998 - 5003. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Zhang, Z. Wang, T. Li, E. N. Tsitsikov, and H.-F. Ding NF-{kappa}B2 mutation targets TRAF1 to induce lymphomagenesis Blood, July 15, 2007; 110(2): 743 - 751. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Legarda-Addison and A. T. Ting Negative Regulation of TCR Signaling by NF-{kappa}B2/p100 J. Immunol., June 15, 2007; 178(12): 7767 - 7778. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Ramsauer, M. Farlik, G. Zupkovitz, C. Seiser, A. Kroger, H. Hauser, and T. Decker Distinct modes of action applied by transcription factors STAT1 and IRF1 to initiate transcription of the IFN-{gamma}-inducible gbp2 gene PNAS, February 20, 2007; 104(8): 2849 - 2854. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. W. Hansberger, J. A. Campbell, P. Danthi, P. Arrate, K. N. Pennington, K. B. Marcu, D. W. Ballard, and T. S. Dermody I{kappa}B Kinase Subunits {alpha} and {gamma} Are Required for Activation of NF-{kappa}B and Induction of Apoptosis by Mammalian Reovirus J. Virol., February 1, 2007; 81(3): 1360 - 1371. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Moore, S. Buonocore, E. Aksoy, N. Ouled-Haddou, S. Goriely, E. Lazarova, F. Paulart, C. Heirman, E. Vaeremans, K. Thielemans, et al. An Alternative Pathway of NF-{kappa}B Activation Results in Maturation and T Cell Priming Activity of Dendritic Cells Overexpressing a Mutated I{kappa}B{alpha} J. Immunol., February 1, 2007; 178(3): 1301 - 1311. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Jorgl, B. Platzer, S. Taschner, L. X. Heinz, B. Hocher, P. M. Reisner, F. Gobel, and H. Strobl Human Langerhans-cell activation triggered in vitro by conditionally expressed MKK6 is counterregulated by the downstream effector RelB Blood, January 1, 2007; 109(1): 185 - 193. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Zhang, Z. Wang, J. Ding, P. Peterson, W. T. Gunning, and H.-F. Ding NF-{kappa}B2 Is Required for the Control of Autoimmunity by Regulating the Development of Medullary Thymic Epithelial Cells J. Biol. Chem., December 15, 2006; 281(50): 38617 - 38624. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Hacker and M. Karin Regulation and Function of IKK and IKK-Related Kinases Sci. Signal., October 17, 2006; 2006(357): re13 - re13. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Andreakos, R. O. Williams, J. Wales, B. M. Foxwell, and M. Feldmann Activation of NF-{kappa}B by the intracellular expression of NF-{kappa}B-inducing kinase acts as a powerful vaccine adjuvant PNAS, September 26, 2006; 103(39): 14459 - 14464. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. K. Yoza, J. Y.-Q. Hu, S. L. Cousart, L. M. Forrest, and C. E. McCall Induction of RelB Participates in Endotoxin Tolerance J. Immunol., September 15, 2006; 177(6): 4080 - 4085. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Matos and P. Jordan Rac1, but Not Rac1B, Stimulates RelB-mediated Gene Transcription in Colorectal Cancer Cells J. Biol. Chem., May 12, 2006; 281(19): 13724 - 13732. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Dong, W. Lutz, T. M. Schroeder, L. A. Bachman, J. J. Westendorf, R. Kumar, and M. D. Griffin Regulation of relB in dendritic cells by means of modulated association of vitamin D receptor and histone deacetylase 3 with the promoter PNAS, November 1, 2005; 102(44): 16007 - 16012. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. N. Moynagh The NF-{kappa}B pathway J. Cell Sci., October 15, 2005; 118(20): 4589 - 4592. [Full Text] [PDF] |
||||
![]() |
P. J. Cejas, L. M. Carlson, D. Kolonias, J. Zhang, I. Lindner, D. D. Billadeau, L. H. Boise, and K. P. Lee Regulation of RelB Expression during the Initiation of Dendritic Cell Differentiation Mol. Cell. Biol., September 1, 2005; 25(17): 7900 - 7916. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Thoetkiattikul, M. H. Beck, and M. R. Strand Inhibitor {kappa}B-like proteins from a polydnavirus inhibit NF-{kappa}B activation and suppress the insect immune response PNAS, August 9, 2005; 102(32): 11426 - 11431. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. D. Morrison, W. Reiley, M. Zhang, and S.-C. Sun An Atypical Tumor Necrosis Factor (TNF) Receptor-associated Factor-binding Motif of B Cell-activating Factor Belonging to the TNF Family (BAFF) Receptor Mediates Induction of the Noncanonical NF-{kappa}B Signaling Pathway J. Biol. Chem., March 18, 2005; 280(11): 10018 - 10024. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Matsumoto, J.-i. Namekawa, M. Muta, T. Nakamura, H. Bando, K. Tohyama, M. Toi, and K. Umezawa Targeting of Nuclear Factor {kappa}B Pathways by Dehydroxymethylepoxyquinomicin, a Novel Inhibitor of Breast Carcinomas: Antitumor and Antiangiogenic Potential In vivo Clin. Cancer Res., February 1, 2005; 11(3): 1287 - 1293. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Wang and G. E. Sonenshein Induction of the RelB NF-{kappa}B Subunit by the Cytomegalovirus IE1 Protein Is Mediated via Jun Kinase and c-Jun/Fra-2 AP-1 Complexes J. Virol., January 1, 2005; 79(1): 95 - 105. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Wu and P. Wang Per-Arnt-Sim domain-dependent association of cAMP-phosphodiesterase 8A1 with I{kappa}B proteins PNAS, December 21, 2004; 101(51): 17634 - 17639. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. E. Munroe and G. A. Bishop Role of Tumor Necrosis Factor (TNF) Receptor-associated Factor 2 (TRAF2) in Distinct and Overlapping CD40 and TNF Receptor 2/CD120b-mediated B Lymphocyte Activation J. Biol. Chem., December 17, 2004; 279(51): 53222 - 53231. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Platzer, A. Jorgl, S. Taschner, B. Hocher, and H. Strobl RelB regulates human dendritic cell subset development by promoting monocyte intermediates Blood, December 1, 2004; 104(12): 3655 - 3663. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Qu, G. Qing, A. Rabson, and G. Xiao Tax Deregulation of NF-{kappa}B2 p100 Processing Involves Both {beta}-TrCP-dependent and -independent Mechanisms J. Biol. Chem., October 22, 2004; 279(43): 44563 - 44572. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. S. Hayden and S. Ghosh Signaling to NF-{kappa}B Genes & Dev., September 15, 2004; 18(18): 2195 - 2224. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Schmidt-Supprian, J. Tian, H. Ji, C. Terhorst, A. K. Bhan, E. P. Grant, M. Pasparakis, S. Casola, A. J. Coyle, and K. Rajewsky I{kappa}B Kinase 2 Deficiency in T Cells Leads to Defects in Priming, B Cell Help, Germinal Center Reactions, and Homeostatic Expansion J. Immunol., August 1, 2004; 173(3): 1612 - 1619. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Liao, M. Zhang, E. W. Harhaj, and S.-C. Sun Regulation of the NF-{kappa}B-inducing Kinase by Tumor Necrosis Factor Receptor-associated Factor 3-induced Degradation J. Biol. Chem., June 18, 2004; 279(25): 26243 - 26250. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. O'Connor, S. D. Shumway, I. J. Amanna, C. E. Hayes, and S. Miyamoto Regulation of Constitutive p50/c-Rel Activity via Proteasome Inhibitor-Resistant I{kappa}B{alpha} Degradation in B Cells Mol. Cell. Biol., June 1, 2004; 24(11): 4895 - 4908. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Speirs, L. Lieberman, J. Caamano, C. A. Hunter, and P. Scott Cutting Edge: NF-{kappa}B2 Is a Negative Regulator of Dendritic Cell Function J. Immunol., January 15, 2004; 172(2): 752 - 756. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Saito, G. Courtois, A. Chiba, N. Yamamoto, T. Nitta, N. Hironaka, M. Rowe, N. Yamamoto, and S. Yamaoka Two Carboxyl-terminal Activation Regions of Epstein-Barr Virus Latent Membrane Protein 1 Activate NF-{kappa}B through Distinct Signaling Pathways in Fibroblast Cell Lines J. Biol. Chem., November 21, 2003; 278(47): 46565 - 46575. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. E. Molestina, T. M. Payne, I. Coppens, and A. P. Sinai Activation of NF-{kappa}B by Toxoplasma gondii correlates with increased expression of antiapoptotic genes and localization of phosphorylated I{kappa}B to the parasitophorous vacuole membrane J. Cell Sci., November 1, 2003; 116(21): 4359 - 4371. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. J. Maier, R. Marienfeld, T. Wirth, and B. Baumann Critical Role of RelB Serine 368 for Dimerization and p100 Stabilization J. Biol. Chem., October 3, 2003; 278(40): 39242 - 39250. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Saitoh, M. Nakayama, H. Nakano, H. Yagita, N. Yamamoto, and S. Yamaoka TWEAK Induces NF-{kappa}B2 p100 Processing and Long Lasting NF-{kappa}B Activation J. Biol. Chem., September 19, 2003; 278(38): 36005 - 36012. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. N. Hatada, R. K. G. Do, A. Orlofsky, H.-C. Liou, M. Prystowsky, I. C. M. MacLennan, J. Caamano, and S. Chen-Kiang NF-{kappa}B1 p50 Is Required for BLyS Attenuation of Apoptosis but Dispensable for Processing of NF-{kappa}B2 p100 to p52 in Quiescent Mature B Cells J. Immunol., July 15, 2003; 171(2): 761 - 768. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Derudder, E. Dejardin, L. L. Pritchard, D. R. Green, M. Korner, and V. Baud RelB/p50 Dimers Are Differentially Regulated by Tumor Necrosis Factor-{alpha} and Lymphotoxin-{beta} Receptor Activation: CRITICAL ROLES FOR p100 J. Biol. Chem., June 20, 2003; 278(26): 23278 - 23284. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Sivakumar, K. J.L. Hammond, N. Howells, K. Pfeffer, and F. Weih Differential Requirement for Rel/Nuclear Factor {kappa}B Family Members in Natural Killer T Cell Development J. Exp. Med., June 16, 2003; 197(12): 1613 - 1621. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Marienfeld, M. J. May, I. Berberich, E. Serfling, S. Ghosh, and M. Neumann RelB Forms Transcriptionally Inactive Complexes with RelA/p65 J. Biol. Chem., May 23, 2003; 278(22): 19852 - 19860. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. R. Muller and U. Siebenlist Lymphotoxin beta Receptor Induces Sequential Activation of Distinct NF-kappa B Factors via Separate Signaling Pathways J. Biol. Chem., March 28, 2003; 278(14): 12006 - 12012. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Pasparakis, M. Schmidt-Supprian, and K. Rajewsky I{kappa}B Kinase Signaling Is Essential for Maintenance of Mature B Cells J. Exp. Med., September 16, 2002; 196(6): 743 - 752. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. J. O'Sullivan and R. Thomas CD40 Ligation Conditions Dendritic Cell Antigen-Presenting Function Through Sustained Activation of NF-{kappa}B J. Immunol., June 1, 2002; 168(11): 5491 - 5498. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |